[This Week's Paid-in Capital Increase] October Second Week Public Offering Schedule

[Asia Economy Reporter Hyunseok Yoo] This month (October) in the second week, Kangstem Biotech and Ecopro will conduct rights offerings.

◆Kangstem Biotech= Kangstem Biotech will conduct a rights offering followed by a general public offering for unsubscribed shares. Existing shareholders will subscribe on the 13th and 14th, and the general public subscription will take place from the 18th to the 19th of the same month.

A total of 12,376,237 shares will be issued to raise 39 billion KRW. The issue price is 3,150 KRW per share. Of the funds raised, 37.7 billion KRW will be used for Phase 3 clinical trials of the atopic dermatitis treatment (Furestem-AD Inj.) and subsequent pipeline clinical trials. Additionally, 1.3 billion KRW will be allocated to research and development (R&D) expenses and operating costs.

Kangstem Biotech is developing treatments for rare and intractable immune diseases such as dermatitis, Crohn's disease, and rheumatoid arthritis using stem cells derived from umbilical cord blood.

◆Ecopro= Ecopro will conduct a rights offering through a general public subscription method. The subscription period is from the 13th of this month to the 1st of next month.

A total of 7,087,918 shares will be issued to raise 676.5 billion KRW. The issue price is 95,441 KRW per share. All the funds raised will be used for acquiring securities of other companies.

Ecopro will conduct a share swap by exchanging the newly issued shares from the large-scale rights offering for shares of Ecopro HN. Additionally, the newly issued shares from the rights offering will be provided to Ecopro HN shareholders who participate in the tender offer.